Combined Feldan Shuttle and Green Cross LabCell NK cell technologies will be used to develop hyperactive NK cell immunotherapies
QUEBEC, Jan. 15, 2018 /PRNewswire/ – Green Cross LabCell, involved in development of next generation biologics, and Feldan Therapeutics, focused on…
